首页> 外文会议>Association in solution IV >STUDYING SOLUTION SELF-ASSEMBLED MORPHOLOGY AND THERMAL STABILITY OF POLYSORBATE FRACTIONS AND THEIR IMPLICATIONS IN MICELLAR DEGRADATION VIA SMALL ANGLE NEUTRON SCATTERING
【24h】

STUDYING SOLUTION SELF-ASSEMBLED MORPHOLOGY AND THERMAL STABILITY OF POLYSORBATE FRACTIONS AND THEIR IMPLICATIONS IN MICELLAR DEGRADATION VIA SMALL ANGLE NEUTRON SCATTERING

机译:小角度中子散射研究溶液的自组装形态和热稳定性及其在胶束降解中的​​意义

获取原文
获取原文并翻译 | 示例

摘要

Pharmaceutical industries add excipients in therapeutic protein formulations to stabilize monoclonal antibodies (mAbs) against surface-induced denaturation and aggregation. Excipients such as commercially available polysorbate (PS) 20 and PS 80 can modulate the interfacial behavior of mAbs in solution due to their amphiphilic nature, and thereby enhance long-term stability and storage of therapeutic protein formulations1. Commercially available PSs used in protein formulations are extremely heterogeneous and contain complex molecular entities which mainly comes from different types of fatty acid esters in the hydrophobic chain1. Recent findings in bio-pharmaceutical industries confirm that the structural heterogeneity and manufacturing byproducts make them susceptible to degrade via ester-hydrolysis and auto-oxidation at pharmaceutically relevant conditions12. The possible consequences of such degradation mechanisms are: (1) loss of surfactant functionality due to change in the PS structure in both unimer and micelle (2) accumulation of degradants that can lead to formation of sub-visible and visible particle in therapeutic formulations. These phenomena can severely impact the product quality and produce unwanted immune responses. Furthermore, these degradation mechanisms produce different degradation profiles due to preferential degradation and can respond differently to the assay techniques typically employed by pharmaceutical industries. Therefore, we performed a design of experiments to determine the micellar morphologies of the individual components of PS 20 and PS 80 using small angle neutron scattering (SANS) for comparison to SANS experiments on selectively degraded, commercial PS solutions with the goal of identifying specific components responsible for the properties of the degraded samples. The stability of the components of PS 20 and PS 80 micelles are studied under thermal stress, confirming that PS molecules with two hydrophobic tail groups are more prone to morphology changes leading to solution instability. To understand the mechanistic pathways of PS degradation, we also investigated the solution physiochemical properties and stability of chemically degraded pharmaceutical PS 20 micelles. In conclusion, our study demonstrates morphological changes of the PS components as a function of temperature which can potentially identify the PS components responsible for degradation under thermal stress. The results of this study may facilitate formulating protein therapeutics with better stability profiles.
机译:制药行业在治疗性蛋白质制剂中添加了赋形剂,以稳定单克隆抗体(mAb)抵抗表面诱导的变性和聚集。诸如市售的聚山梨酸酯(PS)20和PS 80之类的赋形剂由于其两亲性质可以调节溶液中mAb的界面行为,从而增强治疗性蛋白质制剂的长期稳定性和储存性。用于蛋白质制剂的市售PS异质性很强,并且包含复杂的分子实体,这些实体主要来自疏水链中不同类型的脂肪酸酯1。生物制药行业的最新发现证实,结构异质性和制造副产物使它们易于在药物相关条件下通过酯水解和自氧化作用降解[12]。这种降解机理的可能后果是:(1)由于单体和胶束中PS结构的变化而导致的表面活性剂功能丧失(2)降解物的积累,这可能导致在治疗制剂中形成亚可见和可见的颗粒。这些现象会严重影响产品质量并产生有害的免疫反应。此外,由于优先降解,这些降解机理产生不同的降解曲线,并且可以不同地响应制药行业通常采用的测定技术。因此,我们进行了实验设计,使用小角度中子散射(SANS)来确定PS 20和PS 80各个组分的胶束形态,以便与选择性降解的商用PS解决方案的SANS实验进行比较,以鉴定特定组分负责降解样品的特性。在热应力下研究了PS 20和PS 80胶束组分的稳定性,证实具有两个疏水尾基的PS分子更易于发生形态变化,从而导致溶液不稳定。为了了解PS降解的机理,我们还研究了化学降解的药物PS 20胶束的溶液理化性质和稳定性。总之,我们的研究证明了PS组分随温度变化的形态变化,可以潜在地识别出在热应力作用下降解的PS组分。这项研究的结果可能有助于配制具有更好稳定性的蛋白质治疗剂。

著录项

  • 来源
    《Association in solution IV》|2017年|80-80|共1页
  • 会议地点 St. Johns(CA)
  • 作者

    Jannatun Nayem;

  • 作者单位

    University of Delaware and NIST, USA;

  • 会议组织
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号